Nikhil Lalwani - Nov 26, 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role: PRESIDENT & CEO, Director
Signature: /s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Stock symbol: ANIP
Transactions as of: Nov 26, 2024
Transactions value $: -$1,941,442
Form type: 4
Date filed: 11/27/2024, 05:38 PM
Previous filing: Sep 10, 2024
Next filing: Feb 18, 2025

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIP	Common Stock	Options Exercise	$870K	+30K	+8.02%	$29.00	404K	Nov 26, 2024	Direct
transaction	ANIP	Common Stock	Sale	-$1.74M	-30K	-7.43%	$57.95	374K	Nov 26, 2024	Direct	F1
transaction	ANIP	Common Stock	Sale	-$203K	-3.48K	-0.93%	$58.30	370K	Nov 26, 2024	Direct	F2

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIP	Stock Option (right to buy)	Options Exercise	-$870K	-30K	-17.85%	$29.00	138K	Nov 26, 2024	Common Stock	30K	$29.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price.
F2	The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price.
F3	25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.